AMP Capital Investors’s Exact Sciences EXAS Stock Holding History

AMP Capital Investors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-38,887	Closed	-$3.71M	–	460
2021 Q3	$3.71M	Sell	38,887 -3,128	-7%	-$330K	0.02%	620
2021 Q2	$5.24M	Buy	42,015 +299	+0.7%	+$35.7K	0.03%	596
2021 Q1	$5.47M	Buy	41,716 +3,646	+10%	+$499K	0.03%	583
2020 Q4	$5.15M	Sell	38,070 -272	-0.7%	-$32.9K	0.03%	571
2020 Q3	$3.91M	Buy	38,342 +800	+2%	+$69.1K	0.02%	595
2020 Q2	$3.23M	Buy	37,542 +27	+0.1%	+$2.16K	0.02%	620
2020 Q1	$2.19M	Sell	37,515 -2,092	-5%	-$170K	0.02%	641
2019 Q4	$3.64M	Sell	39,607 -15,151	-28%	-$1.33M	0.02%	641
2019 Q3	$5.04M	Buy	54,758 +20,133	+58%	+$2.29M	0.03%	536
2019 Q2	$3.98M	Buy	+34,625	New	+$3.49M	0.02%	585

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AMP Capital Investors's EXAS Position: Q4 2021 in Review

AMP Capital Investors sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 38,887 shares — an estimated $3.71M sold.

AMP Capital Investors first reported a position in EXAS in Q2 2019 and held it in 10 quarters. The position peaked at $5.47M in Q1 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

AMP Capital Investors reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
AMP Capital Investors sold 38,887 Exact Sciences shares in Q4 2021, an estimated $3.71M.
AMP Capital Investors first reported a position in Exact Sciences in Q2 2019 and held it in 10 quarters.
AMP Capital Investors's Exact Sciences position peaked at $5.47M in Q1 2021.
596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.